These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12455916)

  • 1. Osteoprotegerin administration reduces femural bone loss in ovariectomized mice via impairment of osteoclast structure and function.
    Shimizu-Ishiura M; Kawana F; Sasaki T
    J Electron Microsc (Tokyo); 2002; 51(5):315-25. PubMed ID: 12455916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
    Sasaki T
    Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanism of inhibition of osteoclastic resorption of bone and calcified cartilage by long-term pamidronate administration in ovariectomized mature rats.
    Mayahara M; Sasaki T
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):817-26. PubMed ID: 12923892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of osteoprotegerin administration on osteoclast differentiation and trabecular bone structure in osteoprotegerin-deficient mice.
    Yamazaki H; Sasaki T
    J Electron Microsc (Tokyo); 2005 Oct; 54(5):467-77. PubMed ID: 16339792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined treatment with PTH (1-34) and OPG increases bone volume and uniformity of mineralization in aged ovariectomized rats.
    Valenta A; Roschger P; Fratzl-Zelman N; Kostenuik PJ; Dunstan CR; Fratzl P; Klaushofer K
    Bone; 2005 Jul; 37(1):87-95. PubMed ID: 15869920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
    Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
    Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chemically modified tetracycline, CMT-8, on bone loss and osteoclast structure and function in osteoporotic states.
    Sasaki T; Ohyori N; Debari K; Ramamurthy NS; Golub LM
    Ann N Y Acad Sci; 1999 Jun; 878():347-60. PubMed ID: 10415740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclast differentiation and characteristic trabecular bone formation during growth plate destruction in osteoprotegerin-deficient mice.
    Kawana F; Sasaki T
    J Electron Microsc (Tokyo); 2003; 52(6):515-25. PubMed ID: 14756239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biglycan deficiency interferes with ovariectomy-induced bone loss.
    Nielsen KL; Allen MR; Bloomfield SA; Andersen TL; Chen XD; Poulsen HS; Young MF; Heegaard AM
    J Bone Miner Res; 2003 Dec; 18(12):2152-8. PubMed ID: 14672350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracycline/flurbiprofen combination therapy modulates bone remodeling in ovariectomized rats: preliminary observations.
    Aoyagi M; Sasaki T; Ramamurthy NS; Golub LM
    Bone; 1996 Dec; 19(6):629-35. PubMed ID: 8968030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice.
    Zhang J; Dai J; Lin DL; Habib P; Smith P; Murtha J; Fu Z; Yao Z; Qi Y; Keller ET
    J Bone Miner Res; 2002 Jul; 17(7):1256-63. PubMed ID: 12096839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.
    Ominsky MS; Li X; Asuncion FJ; Barrero M; Warmington KS; Dwyer D; Stolina M; Geng Z; Grisanti M; Tan HL; Corbin T; McCabe J; Simonet WS; Ke HZ; Kostenuik PJ
    J Bone Miner Res; 2008 May; 23(5):672-82. PubMed ID: 18433301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast and long acting neoflavonoids dalbergin isolated from Dalbergia sissoo heartwood is osteoprotective in ovariectomized model of osteoporosis: Osteoprotective effect of Dalbergin.
    Choudhary D; Kushwaha P; Gautam J; Kumar P; Verma A; Kumar A; Maurya SW; Siddiqui IR; Mishra PR; Maurya R; Trivedi R
    Biomed Pharmacother; 2016 Oct; 83():942-957. PubMed ID: 27522257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin.
    Shiotani A; Takami M; Itoh K; Shibasaki Y; Sasaki T
    Anat Rec; 2002 Oct; 268(2):137-46. PubMed ID: 12221720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin.
    Mizuno A; Amizuka N; Irie K; Murakami A; Fujise N; Kanno T; Sato Y; Nakagawa N; Yasuda H; Mochizuki S; Gomibuchi T; Yano K; Shima N; Washida N; Tsuda E; Morinaga T; Higashio K; Ozawa H
    Biochem Biophys Res Commun; 1998 Jun; 247(3):610-5. PubMed ID: 9647741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice.
    Oshiro T; Shiotani A; Shibasaki Y; Sasaki T
    Anat Rec; 2002 Apr; 266(4):218-25. PubMed ID: 11920384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse.
    Gruber HE; Rude RK
    Biotech Histochem; 2003 Oct; 78(5):231-6. PubMed ID: 14989640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tea polysaccharide inhibits RANKL-induced osteoclastogenesis in RAW264.7 cells and ameliorates ovariectomy-induced osteoporosis in rats.
    Xu H; Yin D; Liu T; Chen F; Chen Y; Wang X; Sheng J
    Biomed Pharmacother; 2018 Jun; 102():539-548. PubMed ID: 29587240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro.
    Yuan SY; Sheng T; Liu LQ; Zhang YL; Liu XM; Ma T; Zheng H; Yan Y; Ishimi Y; Wang XX
    Chin J Nat Med; 2016 Apr; 14(4):265-269. PubMed ID: 27114313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis.
    Ulrich-Vinther M; Carmody EE; Goater JJ; S balle K; O'Keefe RJ; Schwarz EM
    J Bone Joint Surg Am; 2002 Aug; 84(8):1405-12. PubMed ID: 12177271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.